ThirtyFiveBio
PrivateLast Round
VC Round
Apr 15, 2025
Total Funding Raised
$21.44M
Company Overview
ThirtyFiveBio is a biotechnology company developing first-in-class small-molecule inhibitors of G protein-coupled receptor 35 (GPR35) to treat severe gastrointestinal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ThirtyFiveBio Comparables
Compare ThirtyFiveBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nxera Pharma | 73% | |
| Bristol Myers Squibb | 71% | |
| N-Zyme Biomedical | 70% | |
ThirtyFiveBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 15, 2025 | ||||
| Grant | Jul 2, 2024 | ||||
| Grant | Sep 13, 2023 |
ThirtyFiveBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| AbbVie Ventures | VC Round |
| Innovate UK | Grant |
| Canaan Partners | Seed, VC Round |
| Mayewell Capital | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2025
Raised $3.56M led by Canaan Partners
ThirtyFiveBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ThirtyFiveBio's valuation, stock price, and market status.